Enfermedades relacionadas con Helicobacter pylori: dispepsia, úlcera y cáncer gástrico

Gisbert, 2002, Review article: Helicobacter pylori “rescue” regimen when proton pump inhibitor-based triple therapies fail, Aliment Pharmacol Ther, 16, 1047, 10.1046/j.1365-2036.2002.01276.x

Gatta, 2010, Antibiotic susceptibility patterns in Helicobacter pylori in 1,617 Patients Performing an EGDS, Gastroenterology, 138, S33

Chung, 2010, Prevalence and molecular mechanism of fluoroquinolone resistance of Helicobacter pylori strains in Korea, Gastroenterology, 138, S337

Wang, 2010, Is levofloxacin a feasible option for Helicobacter pylori rescue therapy in Singapore?, Gastroenterology, 138, S339

O’Connor, 2010, Changing patterns of clarithromycin and metronidazole resistance amongst Helicobacter pylori strains in a reference centre, Gastroenterology, 138, S32

Vilaichone, 2010, Antibiotic resistance of Helicobacter pylori in Thailand, Gastroenterology, 138, S338

Gisbert, 1999, Helicobacter pylori and gastroesophageal reflux disease: friends or foes?, Hepatogastroenterology, 46, 1023

Chung, 2010, Helicobacter pylori serology inversely correlated with the risk and severity grades of reflux esophagitis: a matched case-control study of 5,616 health check-up Koreans, Gastroenterology, 138, S399

Zou, 2010, Helicobacter pylori infection, atrophic gastritis and associated factors: the Systematic Investigation of Gastrointestinal Diseases in China (SILC), Gastroenterology, 135, S23

Kato, 2010, The change of reflux and dysmotility symptoms by questionnaire after eradication of H. pylori in Japanese general population, Gastroenterology, 138, S398

Churikova, 2010, Helicobacter pylori eradication changes course of reflux-esophagitis in the patients with gastroesophageal reflux disease(GERD), Gastroenterology, 138, S649

Gisbert, 1999, Helicobacter pylori test-and-treat’ strategy for dyspeptic patients, Scand J Gastroenterol, 34, 644, 10.1080/003655299750025822

Yamazaki, 2010, A ten-year study on the long-term effect of Helicobacter pylori eradication therapy on dyspepsia symptoms in Japan, Gastroenterology, 138, S487

Moayyedi, 2005, Eradication of Helicobacter pylori for non-ulcer dyspepsia, Cochrane Database Syst Rev, 10.1002/14651858.CD002096.pub2

Mazzoleni, 2010, Dyspeptic symptoms after eradication of Helicobacter pylori in patients with functional dyspepsia. Heroes-12 Trial (Helicobacter Eradication Relief of Dyspetic Symptoms), Gastroenterology, 138, S719

Gisbert, 1999, H. pylori-negative duodenal ulcer prevalence and causes in 774 patients, Dig Dis Sci, 44, 2295, 10.1023/A:1026669123593

Gisbert, 2009, Review article: Helicobacter pylori-negative duodenal ulcer disease, Aliment Pharmacol Ther, 30, 791, 10.1111/j.1365-2036.2009.04105.x

Hansen, 2010, Uncomplicated peptic ulcer: HP-status and NSAID/aspirin use — a prospective study from three Danish centres, Gastroenterology, 138, S401

Gisbert, 2010, Eradication of Helicobacter pylori for the prevention of peptic ulcer rebleeding. Long-term follow-up study of 800 patients, Gastroenterology, 138, S334

Gisbert, 2006, Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis, Am J Gastroenterol, 101, 848, 10.1111/j.1572-0241.2006.00528.x

Manguso, 2010, Detection of HP infection in patients with peptic ulcer disease complicated by hemorrhage after assumption of NSAIDs, Gastroenterology, 138, S399

De Sablet, 2010, European phylogenetic origin of Helicobacter pylori strains as a risk factor for premalignant gastric lesions in Colombia, Gastroenterology, 138, S22

Foertsch, 2010, Development of a new electrochemical device for rapid Helicobacter pylori detection, Gastroenterology, 138, S512

Neumann, 2010, Immediate detection of helicobacter infection with a novel electrochemical system: feasibility and comparison of diagnostic yield with immunohistochemistry, 13C urea breath test and Helicobacter urease test, Gastroenterology, 138, S114

Kim, 2010, United clotest is superior to test of separate specimens from the antrum and body in detecting Helicobacter pylori, Gastroenterology, 138, S338

O’Connor, 2010, Test Treat and Re-Test. Who is best at checking for Helicobacter pylori eradication after apositive urea breath test (UBT), family physicians or gastroenterologists?, Gastroenterology, 138, S33

Okubo, 2010, Change in gastric mucosal patterns seen by magnifying NBI endoscopy during H. pylori eradication, Gastroenterology, 71, AB260

DuBois, 2005, Iron-deficiency anemia and Helicobacter pylori infection: a review of the evidence, Am J Gastroenterol, 100, 453, 10.1111/j.1572-0241.2005.30252.x

Malfertheiner, 2007, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, 56, 772, 10.1136/gut.2006.101634

Chey, 2007, American College of Gastroenterology guideline on the management of Helicobacter pylori infection, Am J Gastroenterol, 102, 1808, 10.1111/j.1572-0241.2007.01393.x

Gisbert, 2010, Helicobacter pylori and iron-deficiency anaemia (IDA): a meta-analysis of casecontrol studies, Gastroenterology, 138, S401

Harris, 2010, Helicobacter pylori-associated hypochlorhydria in children relates to the development of iron deficiency, Gastroenterology, 138, S23

Pérez Nyssen, 2010, Effect of Helicobacter pylori eradication on iron-deficiency anaemia (IDA): a meta-analysis of randomized clinical trials, Gastroenterology, 138, S400

Semino-Mora, 2010, Coronary artery in situ Helicobacter pylori and its association with stress and atherosclerosis in monkeys, Gastroenterology, 138, S22

Omata, 2010, The jury is in: Helicobacter pylori infection is not associated with atherosclerosis, Gastroenterology, 138, S291

Kim, 2010, The association between Helicobacter pylori seropositivity and colorectal adenoma: a case-control study, Gastroenterology, 135, S182

Sumanac, 2010, Is there a relationship between H. pylori prevalence and overweight? a systematic review of observational studies, Gastroenterology, 138, S399

Kim, 2010, Comparative study of Helicobacter pylori eradication rates of three-times-daily high dose lansoprazole/amoxicillin dual therapy versus standard triple therapy, Gastroenterology, 138, S336

Graham, 2010, Treatment success with dual proton pump inhibitor plus amoxicillin H. pylori therapy or PPI, amoxicillin, clarithromycin triple therapy, Gastroenterology, 138, S468

Sánchez-Delgado, 2010, Effectiveness of a 10-day triple therapy combining potent acid inhibition with amoxicillin and metronidazole for H. pylori eradication in clinical practice. A pilot study, Gastroenterology, 138, S337

Calvet, 2005, Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: a multicenter randomized trial, Am J Gastroenterol, 100, 1696, 10.1111/j.1572-0241.2005.50019.x

Fuccio, 2007, Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication, Ann Intern Med, 147, 553, 10.7326/0003-4819-147-8-200710160-00008

Flores, 2010, Duration of proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis, Gastroenterology, 138, S340

Gene, 2003, Triple vs. quadruple therapy for treating Helicobacter pylori infection: a metaanalysis, Aliment Pharmacol Ther, 17, 1137, 10.1046/j.1365-2036.2003.01566.x

Malfertheiner, 2010, Quadruple therapy with bismuth subcitrate potassium, metronidazole, tetracycline, and omeprazole is superior to triple therapy with omeprazole, amoxicillin, and clarithromycin in the eradication of Helicobacter pylori, Gastroenterology, 138, S33, 10.1016/S0016-5085(10)60150-3

Gisbert, 2010, Sequential therapy for Helicobacter pylori eradication: a critical review, J Clin Gastroenterol, 44, 313, 10.1097/MCG.0b013e3181c8a1a3

Remes Troche, 2010, Sequential therapy vs. standard triple therapy as treatment of Helicobacter pylori infection. A prospective, randomized, parallel-group, openlabel study in Mexico, Gastroenterology, 138, S336

Hsu, 2010, Search for a grade a therapy for Helicobacter pylori infection: 14-day sequential or sequential-concomitant hybrid therapy, Gastroenterology, 138, S111

Sánchez-Delgado, 2008, Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice, Am J Gastroenterol, 103, 2220, 10.1111/j.1572-0241.2008.01924.x

Molina-Infante, 2010, Clarithromycin or levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication: a randomized clinical trial, Gastroenterology, 138, S335

Mahachai, 2010, Sequential therapy in clarithromycin resistant Helicobacter pylori based on PCR molecular test, Gastroenterology, 138, S334

Romano, 2010, Levofloxacin-based sequential therapy vs clarithromycin-based sequential therapy for eradication of H. pylori infection, Gastroenterology, 138, S335

Gisbert, 2010, Sequential therapy for Helicobacter pylori eradication: a critical review, Gastroenterology, 138, S335

Essa, 2009, Meta-analysis: fourdrug, three-antibiotic, non-bismuth-containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradication, Helicobacter, 14, 109, 10.1111/j.1523-5378.2009.00671.x

Kim, 2010, Efficacy of the 14-day quadruple regimen (proton pump inhibitor, bismuth, tetracycline and metronidazole) as a rescue therapy after failure with the 10-days sequential therapy for eradication of Helicobacter pylori, Gastroenterology, 138, S470

Vaiciunas, 2010, Floating-bioadhesive microspheres of clarithromycin versus antibacterial agent ceragenin CsA-13 for eradication of Helicobacter pylori resistant: meta-analysis, Gastroenterology, 138, S339

Gotteland, 2006, Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?, Aliment Pharmacol Ther, 23, 1077, 10.1111/j.1365-2036.2006.02868.x

Park, 2010, The effect of probiotics and mucoprotective agents on PPI-based triple therapy for eradication of Helicobacter pylori, Gastroenterology, 138, S335

Tomtitchong, 2010, The green tea catechin epigallocatechin-3-gallate inhibits H. pylori-induced and EGF-induced ERK signaling in A431 epithelial cells, Gastroenterology, 138, S348

Ming, 2010, Effect of traditional medicinal plants against Helicobacter Pylori, Gastroenterology, 138, AB261

Enomoto, 2010, Inhibitory effects of Japanese apricot (Prunus Mume Siebold ET Zucc.; Urne), on Helicobacter pylori-related chronic gastritis, Gastroenterology, 138, S401

Chung, 2010, Randomized comparison of one or two week bismuth based quadruple therapy for salvage Helicobacter pylori eradication, Gastroenterology, 138, S337

Gisbert, 2006, Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure, Aliment Pharmacol Ther, 23, 35, 10.1111/j.1365-2036.2006.02737.x

Gisbert, 2010, Second-line rescue therapy with levofloxacin after H. pylori treatment failure. A Spanish multicenter study of 657 patients, Gastroenterology, 138, S335

Gisbert, 2010, Helicobacter pylori levofloxacin-based rescue option in patients allergic to penicillin failing a previous treatment with clarithromycin and metronidazole, Gastroenterology, 138, S339

Gisbert, 2006, Third-line rescue therapy with levofloxacin after two H. pylori treatment failures, Am J Gastroenterol, 101, 243, 10.1111/j.1572-0241.2006.00457.x

Suzuki, 2010, Sitafloxacin-based third-line eradication of H. pylori, Gastroenterology, 138, S340

Furuta, 2010, Comparison of triple rabeprazole/metronidazole/sitafloxacin therapy with triple rabeprazole/amoxicillin/sitafloxacin therapy as the third rescue regimen for eradication of H. pylori, Gastroenterology, 138, S337

Marshall, 2010, Deliberate repeated reinfection of volunteers with their own strain of Helicobacter pylori shows that natural immunity is not protective, Gastroenterology, 138, S582